Browse by UCL people
Group by: Type | Date
Number of items: 12.
Article
Adeleke, S;
Latifoltojar, A;
Sidhu, H;
Galazi, M;
Shah, TT;
Clemente, J;
Davda, R;
... Punwani, S; + view all
(2019)
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
BMC Medical Imaging
, 19
, Article 90. 10.1186/s12880-019-0380-y.
|
 |
|
Kim, M;
Torrealdea, F;
Adeleke, O;
Rega, M;
Evans, V;
Beeston, T;
Soteriou, K;
... Golay, X; + view all
(2019)
Challenges in glucoCEST MR body imaging at 3 Tesla.
Quantitative Imaging in Medicine and Surgery
, 9
(10)
pp. 1628-1640.
10.21037/qims.2019.10.05.
|
|
|
Miller, RE;
Brown, NE;
Speirs, A;
Shaw, HM;
Adeleke, S;
Gougis, P;
Bennett, P;
... Kristeleit, RS; + view all
(2016)
The use of next generation sequencing (NGS) to guide patient selection for phase 1 clinical trials.
Annals of Oncology
, 27
(Suppl 6)
pp. 114-135.
10.1093/annonc/mdw368.44.
|
|
Tran, M;
Latifoltojar, A;
Neves, J;
Papoutsaki, M-V;
Gong, Y;
Comment, A;
Costa, A;
... Punwani, S; + view all
(2019)
First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma.
BJR Case Reports
, 5
(3)
, Article 20190003. 10.1259/bjrcr.20190003.
|
|
Book chapter
|
Una-Cidon, E;
Adeleke, S;
Masters, B;
Wood, V;
(2016)
Gefitinib.
In: Una-Cidon, E, (ed.)
The Easy Book of Cancer Pharmacology.
nova science publishers
|
Conference item
|
Adeleke, S;
(2019)
Fat fraction provides classification and treatment response assessment of metastatic lymph nodes for patients with radio-recurrent prostate cancer.
Presented at: ISMRM 27th Annual Meeting and Exhibition, Montreal, QC, Canada.
|
|
Adeleke, S;
Papoutsaki, M-V;
Sidhu, H;
Bainbridge, A;
Price, D;
Carnell, D;
Mendes, R;
(2018)
Hydrogen magnetic resonance spectroscopy: a technique for predicting clinical outcome in patients with head & neck squamous cell cancer with locally advanced cervical nodal disease.
Presented at: Joint Annual Meeting ISMRM-ESMRMB, Paris, France.
|
|
Dillon, MT;
Espinasse, A;
Ellis, S;
Mohammed, K;
Grove, LG;
McLellan, L;
Smith, SA;
... Harrington, KJ; + view all
(2017)
A Phase I dose-escalation study of ATR inhibitor monotherapy with AZD6738 in advanced solid tumors (PATRIOT Part A).
Presented at: Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC.
|
|
Poster
|
Dillon, M;
Ellis, S;
Grove, L;
McLellan, L;
Clack, G;
Smith, S;
Laude, J;
... Harrington, K; + view all
(2016)
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours.
Presented at: ASCO 2016 Annual Meeting: Poster Session, Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics, Chicago.
|
|
Forster, M;
Mendes, R;
Harrington, K;
Guerrero-Urbano, T;
Baines, H;
Spanswick, V;
Ensell, L;
... Beare, S; + view all
(2016)
A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC).
Presented at: 2016 ASCO Annual Meeting, Chicago, IL, USA.
|
|
Harrington, K;
Forster, M;
Dillon, M;
Grove, L;
Adeleke, S;
Chen, S;
Diamond, J;
... Greenberg, J; + view all
(2016)
Patritumab or Placebo Plus Cetuximab and Platinum-Based Therapy in Squamous Cell Carcinoma of the Head and Neck (SCCHN): a Phase 2 Study.
Presented at: ASCO 2016 Annual Meeting: Poster Session, Head and Neck Cancer, Chicago.
|
Thesis
|
Adeleke, Sola;
(2021)
Qualitative and quantitative whole-body MRI assessment of metastatic disease in patients with radio-recurrent prostate cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
